- US-listed companies
- Shockwave Medical, Inc.
- Income statement
Shockwave Medical, Inc.【SWAV】Income statement
Market cap
P/E ratio
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Revenue | 43 | 68 | 237 | 490 | 730 |
| Revenue growth (%) | - | ||||
| Cost of revenue | 17 | 21 | 41 | 65 | 95 |
| Gross profit | - | 47 | 196 | 425 | 635 |
| Gross margin (%) | - | ||||
| Research & development | 33 | 37 | 51 | 82 | 146 |
| Operating margin (%) | |||||
| Operating income | -52 | -66 | -1 | 124 | 159 |
| Operating expenses | 95 | 112 | 197 | 301 | 476 |
| Income before tax | -51 | -66 | -9 | 121 | 174 |
| Pretax margin (%) | -118.9 | -96.8 | -3.7 | 24.7 | 23.9 |
| Provision for income taxes | 0 | 0 | 0 | -95 | 27 |
| Effective tax rate (%) | |||||
| Net income | -51 | -66 | -9 | 216 | 147 |
| Net income margin (%) | |||||
| Earnings per share | - | - | - | 6.02 | 4.01 |
| Diluted EPS | - | - | - | 5.7 | 3.85 |
| EBITDA | - | - | - | ||
| EBITDA margin (%) | - | - | - |